{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-044690","form_type":"8-K","ticker":"NTLA","cik":"0001652130","company_name":"Intellia Therapeutics, Inc.","filed_at":"2024-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.985929+00:00","generated_at":"2026-06-05T17:10:36.727278+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Intellia Therapeutics expands ATM equity facility from $400M to $750M","bullets":["Intellia increased at-the-market equity offering facility from $400M to $750M via amendment to Jefferies Sales Agreement.","As of 2/23/24, ~$374M of shares sold; additional $350M authorized under new prospectus supplement.","Remaining unsold shares under existing prospectus: ~$25.7M.","Jefferies LLC continues as sales agent, receiving 3.0% of gross proceeds."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-044690","json":"https://secwatch.observer/filing/0001193125-24-044690.json","markdown":"https://secwatch.observer/filing/0001193125-24-044690.md","text":"https://secwatch.observer/filing/0001193125-24-044690.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1652130/000119312524044690/0001193125-24-044690-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1652130/000119312524044690/d762897d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T17:10:36.727278+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"08274deec440ed676395fc423c16e88eea9da9de","claim":"Intellia Therapeutics, Inc. amended Sales Agreement with Jefferies LLC valued at increase from $400,000,000 to $750,000,000 (effective 2024-02-23).","evidence_excerpt":"On February 23, 2024, the Company entered into an amendment to the Sales Agreement to increase the size of the at-the-market offering program from $400,000,000 to $750,000,000.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1652130/000119312524044690/0001193125-24-044690-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Jefferies LLC"},{"label":"Value","value":"increase from $400,000,000 to $750,000,000"},{"label":"Effective","value":"2024-02-23"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}